Linda Marban & Cantor Fitzgerald
2 shared events · Importance 3 · Last updated Sep 03, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Linda Marban: CEO who made positive statements about Deramiocel; now named in securities fraud lawsuits.
Cantor Fitzgerald: Analyst firm that published a negative note on the FDA briefing documents.
Jul 27, 2026 · 305 articles
Regulatory
Linda Marban: Capricor's CEO, whose positive statements about HOPE-3 and Deramiocel are cited in the complaint as materially misleading.
Cantor Fitzgerald: Cantor Fitzgerald analyst Kristen Kluska published an investor note stating the FDA briefing documents paint an ugly picture and raise concerns about the integrity of data collection, a view cited in the complaint.
Aug 10, 2026 · 267 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Linda Marban and Cantor Fitzgerald interact across events, view sentiment trends, and discover connected entities.
Open Dashboard